Wakhloo, Debia http://orcid.org/0000-0003-3288-857X
Scharkowski, Franziska http://orcid.org/0000-0001-9112-4444
Curto, Yasmina http://orcid.org/0000-0001-8087-360X
Javed Butt, Umer
Bansal, Vikas http://orcid.org/0000-0002-0944-7226
Steixner-Kumar, Agnes A. http://orcid.org/0000-0001-7913-2716
Wüstefeld, Liane
Rajput, Ashish http://orcid.org/0000-0002-6741-8861
Arinrad, Sahab http://orcid.org/0000-0002-7083-1358
Zillmann, Matthias R. http://orcid.org/0000-0002-4222-0947
Seelbach, Anna http://orcid.org/0000-0002-7908-7369
Hassouna, Imam
Schneider, Katharina
Qadir Ibrahim, Abdul http://orcid.org/0000-0003-3452-8500
Werner, Hauke B. http://orcid.org/0000-0002-7710-5738
Martens, Henrik http://orcid.org/0000-0002-5589-983X
Miskowiak, Kamilla http://orcid.org/0000-0003-2572-1384
Wojcik, Sonja M.
Bonn, Stefan
Nacher, Juan
Nave, Klaus-Armin http://orcid.org/0000-0001-8724-9666
Ehrenreich, Hannelore http://orcid.org/0000-0001-8371-5711
Article History
Received: 15 October 2019
Accepted: 12 February 2020
First Online: 9 March 2020
Competing interests
: H.E. has submitted/holds user patents for EPO in stroke, schizophrenia, and M.S. Henrik Martens is an employee of Synaptic Systems GmbH. Apart from that, the authors declare no competing interests.